Cymerus™ MSCs therapy(Cynata)

N/A

Report date: 2024/09/19 17:35:12

Base Information

Drug NameCymerus™ MSCs therapy(Cynata)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsCoronary DiseaseHeart DiseasesIdiopathic Pulmonary Fibrosis +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCynata Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCynata Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsCoronary DiseaseHeart DiseasesIdiopathic Pulmonary Fibrosis +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A